Skip to main content
SpringerLink
Log in

Why the Spike Protein is Relevant for COVID-19 Therapeutics

  • Chapter
  • First Online:
SARS-CoV-2 Spike Protein Convergent Evolution

Part of the book series: SpringerBriefs in Microbiology ((BRIEFSMICROBIOL))

  • 372 Accesses

Abstract

The Spike protein critical residues focus on the receptor-binding domain, and more specifically on the receptor binding motif.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 16.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Author information

Authors and Affiliations

  1. North-Western Tuscany Blood Bank, Pisa University Hospital, Azienda Ospedaliera Universitaria Pisana, Pisa, Italy

    Dr. Daniele Focosi

Authors
  1. Dr. Daniele Focosi
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Daniele Focosi .

Rights and permissions

Reprints and permissions

Copyright information

© 2021 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Focosi, D. (2021). Why the Spike Protein is Relevant for COVID-19 Therapeutics. In: SARS-CoV-2 Spike Protein Convergent Evolution. SpringerBriefs in Microbiology. Springer, Cham. https://doi.org/10.1007/978-3-030-87324-0_1

Download citation

Publish with us

Policies and ethics

Search

Navigation